SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,995 | +33222.2% | 25,000 | +100.0% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 12,500 | 0.0% | 0.00% | – |
| Q3 2022 | $54,000 | -8.5% | 12,500 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -7.8% | 12,500 | 0.0% | 0.00% | – |
| Q1 2022 | $64,000 | -14.7% | 12,500 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $75,000 | -27.9% | 12,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $104,000 | -26.8% | 12,500 | -20.5% | 0.00% | 0.0% |
| Q2 2021 | $142,000 | -24.9% | 15,733 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $189,000 | -23.8% | 16,161 | -2.4% | 0.00% | -50.0% |
| Q4 2020 | $248,000 | +37.8% | 16,558 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $180,000 | -2.2% | 16,558 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $184,000 | +33.3% | 16,558 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $138,000 | +19.0% | 16,558 | +2.5% | 0.00% | 0.0% |
| Q4 2019 | $116,000 | -17.1% | 16,148 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $140,000 | -25.5% | 16,148 | +1.5% | 0.00% | -50.0% |
| Q2 2019 | $188,000 | -5.1% | 15,904 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $198,000 | +11.9% | 15,904 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $177,000 | -17.3% | 15,904 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $214,000 | -11.2% | 15,938 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $241,000 | -18.6% | 15,938 | +3.4% | 0.00% | 0.0% |
| Q1 2018 | $296,000 | -4.8% | 15,409 | -0.6% | 0.00% | 0.0% |
| Q4 2017 | $311,000 | +58.7% | 15,497 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $196,000 | +39.0% | 15,497 | +3.5% | 0.00% | 0.0% |
| Q2 2017 | $141,000 | +93.2% | 14,970 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $73,000 | +10.6% | 14,970 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $66,000 | +22.2% | 14,970 | +19.2% | 0.00% | – |
| Q3 2016 | $54,000 | -12.9% | 12,558 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $62,000 | -27.9% | 12,558 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $86,000 | -7.5% | 12,558 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $93,000 | +29.2% | 12,558 | -2.1% | 0.00% | 0.0% |
| Q3 2015 | $72,000 | -74.8% | 12,829 | -50.0% | 0.00% | 0.0% |
| Q2 2015 | $286,000 | +42.3% | 25,658 | +100.0% | 0.00% | -50.0% |
| Q1 2015 | $201,000 | -48.7% | 12,829 | -50.2% | 0.00% | 0.0% |
| Q4 2014 | $392,000 | +182.0% | 25,738 | +100.0% | 0.00% | +100.0% |
| Q3 2014 | $139,000 | -34.1% | 12,869 | -6.6% | 0.00% | -50.0% |
| Q2 2014 | $211,000 | -35.7% | 13,778 | -23.9% | 0.00% | -33.3% |
| Q1 2014 | $328,000 | +29.6% | 18,115 | -0.4% | 0.00% | +50.0% |
| Q4 2013 | $253,000 | -19.4% | 18,188 | -39.3% | 0.00% | 0.0% |
| Q3 2013 | $314,000 | +34.2% | 29,944 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $234,000 | – | 29,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |